Schrödinger Stock (NASDAQ:SDGR)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$17.99

52W Range

$16.67 - $38.00

50D Avg

$18.93

200D Avg

$22.69

Market Cap

$1.33B

Avg Vol (3M)

$581.73K

Beta

1.50

Div Yield

-

SDGR Company Profile


Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences industry, as well as to customers in materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.

Show More

Industry

Medical - Healthcare Information Services

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

867

IPO Date

Feb 06, 2020

Website

SDGR Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 22Dec 21Dec 20
Drug Discovery Contribution$1.95M--
Hosted Software-$11.08M$9.19M
Software Contribution-$1.00M-
Revenue From Contract With Customer Before Software Contribution-$112.24M-
Professional Services-$9.27M$9.56M
On Premise Software-$74.60M$58.31M
Software Products And Services-$113.24M$92.53M
Maintenance-$17.29M$14.46M
Contribution--$1.00M
Revenue From Contract With Customer Before Contribution--$91.53M

Fiscal year ends in Dec 23 | Currency in USD

SDGR Financial Summary


Dec 23Dec 22Dec 21
Revenue$216.67M$180.96M$137.93M
Operating Income$-177.45M$-149.12M$-111.44M
Net Income$40.72M$-149.19M$-101.22M
EBITDA$-177.45M$-144.78M$-119.95M
Basic EPS-$-2.10$-1.43
Diluted EPS-$-2.10$-1.43

Fiscal year ends in Dec 23 | Currency in USD

Latest Earnings Call Transcripts


Q2 24Aug 01, 24 | 12:46 AM
Q1 24May 01, 24 | 12:00 AM
Q4 23Feb 28, 24 | 8:15 PM

Peer Comparison


TickerCompany
GEHCGE HealthCare Technologies Inc.
TXG10x Genomics, Inc.
VEEVVeeva Systems Inc.
ACCDAccolade, Inc.
PGNYProgyny, Inc.
HQYHealthEquity, Inc.
DOCSDoximity, Inc.
CERTCertara, Inc.
TDOCTeladoc Health, Inc.
AMWLAmerican Well Corporation